Related Experiment Video
Updated: May 22, 2026

07:12
Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells
Published on: September 9, 2021
A quantitative TR-FRET plate reader immunoassay for measuring autophagy.
Michael K Hancock1, Spencer B Hermanson, Nicholas J Dolman
1Discovery & ADMET-TOX Systems--Life Technologies Corporation, Madison, WI, USA. michael.hancock@lifetech.com
Autophagy
|May 25, 2012
Summary
Researchers developed a new quantitative assay to measure cellular autophagy activity. This TR-FRET immunoassay specifically detects LC3B-II, offering a scalable and automatable method for high-throughput screening of autophagic flux.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Autophagy is crucial for cellular homeostasis, involving the degradation of cellular components via lysosomes.
- Dysregulation of autophagy is linked to various diseases, highlighting the need for accurate quantification methods.
- Existing methods like immunoblotting and imaging have limitations in objectivity and scalability.
Purpose of the Study:
- To develop a facile, quantitative, and scalable assay for measuring cellular autophagic activity.
- To overcome limitations of traditional autophagy detection methods.
- To enable high-throughput screening of autophagy modulators and autophagic flux.
Main Methods:
- Generation of a quantitative plate reader assay using Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET).
- Utilized GFP-tagged LC3B (microtubule-associated protein 1A/1B-light chain 3 B) as a TR-FRET acceptor.
- Screened and identified a specific antibody with preferential affinity for the lipidated LC3B-II form.
Main Results:
- Developed a TR-FRET immunoassay for quantifying autophagic activity based on LC3B-II detection.
- The assay provides quantitative and objective results, surpassing traditional methods.
- Demonstrated the assay's utility in detecting changes in autophagy and estimating autophagic flux.
Conclusions:
- The TR-FRET immunoassay offers a robust, scalable, and automation-friendly platform for autophagy research.
- This method facilitates quantitative assessment of autophagic activity and flux.
- The assay is suitable for high-throughput screening applications in drug discovery and disease research.

